- Record: found
- Abstract: found
- Article: not found
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
J G McHutchison
1 ,
S C Gordon ,
E R Schiff ,
M L Shiffman ,
W M Lee ,
V K Rustgi ,
Z D Goodman ,
M H Ling ,
S Cort ,
J K Albrecht
Nov 19 1998
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Only 15 to 20 percent of patients with chronic hepatitis C have a sustained virologic response to interferon therapy. We compared the efficacy and safety of recombinant interferon alfa-2b alone with those of a combination of interferon alfa-2b and ribavirin for the initial treatment of patients with chronic hepatitis C.